Mulligan SP, Opat S, Marlton P, Kuss B, et al. Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia. Br J Haematol 2022;198:790-793.
PMID: 35702012